Learn more about whether Alvotech or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

CureVac (CVAC) has reported its fourth quarter 2024 financial results, generating mixed reactions from investors as the company balances ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

S&P Global expects inflation to remain closer to 3.0% in 2025 as tariffs result in higher prices along the domestic supply ...

Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

Ethris reported initial positive Phase I data for its intranasal mRNA vaccine candidate, ETH47. "Ethris and Lonza to develop mRNA vaccines for respiratory conditions ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...